The occurrence of cancer at the site of silicone breast implantation has been linked to mutations in the JAK1/STAT3 signaling pathway and the TP53 gene, which are involved in the modulation and prevention of clonal expansion of tumor cells [53,54,55]. Here, TP53 is linked to neoplasm.